For the first time, researchers have identified at least three unique subtypes of a rare type of bone cancer, potentially transforming clinical trials and patient care.
The Indo-US Bridging RARE Summit 2024 took place in New Delhi, India from November 16 to November 18. The Summit saw key speakers from India and the US discuss various aspects of rare diseases, orphan drug clinical trials and diversity, equity and inclusion for orphan drugs.
New York [US], November 13: Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the Frontier X Plus from the U.S. FDA. The Frontier X Plus is an innovative single-lead, continuous ECG monitor that is worn around the chest and w
Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to treat a variety of cancers. Researchers were able to integrate three different functionalities in the antibody, which combined significantly increased the action of T ce
The All India Institute of Medical Sciences in New Delhi (AIIMS, New Delhi), recognised as a leader in stroke treatment in India, has announced the launch of the GRASSROOT (Gravity Stent-Retriever System for Reperfusion of Large Vessel Occlusion Stroke Trial) clinical trial to assess the saf
Under this agreement, Sun Pharma will hold exclusive global rights to commercialise Fibromun, while Philogen will continue conducting pivotal clinical trials, pursue marketing authorisation from regulatory bodies, and manufacture the product.
When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early
Coimbatore (Tamil Nadu) [India], September 18: With the rise in the number of people getting addicted to harmful habits such as alcohol and drug addiction, it is imperative evidence-based treatments are being actively considered for helping recovery of individuals struggling with alcohol and
The Indian Council of Medical Research (ICMR) has formalised a Memorandum of Agreements (MoAs) with multiple sponsors under its Network of Phase 1 Clinical Trials.
As per the MoA, the Indian Council of Medical Research (ICMR) will fund the Phase I clinical trial costs, including the costs relating to the conduct, investigations, and monitoring of the clinical trial. The trial will be conducted at the ICMR network sites in India.
Raichur (Karnataka) [India], August 28: In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship product, sRbumin® - recombinant human albumin® 20% (rHA), becoming the
Several lawmakers have urged the US Food and Drug Administration to initiate an investigation over US biopharmaceutical companies conducting clinical trials alongside the People's Liberation Army (PLA) in Xinjiang, a press release by The Select Committee on the Chinese Communist Party (SCCCP